RE:RE:New Press Release - Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive ChairI think that investors were hoping, as you said, for more but specifically to an update on the sales of the STEM division but, it was not the goal of that meeting. They provided a good overall view of what is going on at the end of it though.
Looking at the technical chart, the price wants to move higher and volume for the past three weeks have been higher than usual so, all-in-all, it is looking good.
GLTA